Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Mice without the Sp6 gene have problems developing several body parts, including hair, teeth, limbs, and lungs.

Sdr16c5 and Sdr16c6 genes regulate a key point in lipid production that affects eye and skin gland function.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Integrin alpha-6 and p63 proteins may play a role in hair loss and are important for hair growth and maintenance.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

Higher IL-21 levels may help predict alopecia areata activity.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Lgr6+ cells are important for tissue repair and could be a target for treating cancer and other diseases.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

PRP-exosomes improve hair growth and reduce inflammation.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Systemic sclerosis skin shows varied gene patterns, suggesting potential for personalized treatment.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.